HLA Typing for Transplant Market to Grow with a CAGR of 6.01% through 2029
Rising advancements in molecular biology and genomics is
expected to drive the Global HLA Typing for Transplant Market growth in the
forecast period, 2025-2029
According to TechSci Research report, “HLA Typing
for Transplant Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2029F”, the Global HLA Typing for Transplant
Market stood at USD 1.02 billion in 2023 and is anticipated to grow with a CAGR
of 6.01% in the forecast period, 2025-2029. The Global HLA Typing for Transplant Market is primarily driven by the increasing need for organ and tissue transplants. Factors such as the rising prevalence of chronic diseases, an aging population, and advancements in surgical procedures have contributed to a higher demand for transplants. Diseases like end-stage renal disease, heart failure, and liver cirrhosis often require organ transplantation for patient survival. HLA typing ensures compatibility between donors and recipients, minimizing the risk of graft rejection or graft-versus-host disease (GVHD), thus enhancing the success rate of these critical procedures.
Technological advancements in molecular biology and genomics have significantly influenced HLA typing methods. Traditional approaches, such as serological testing, are being replaced by more accurate DNA-based techniques like Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and High-Resolution HLA Typing. These innovations provide detailed HLA profiles, improving donor-recipient matching and reducing post-transplant complications, thereby driving market growth.
HLA typing extends beyond organ transplantation and finds increasing applications across healthcare. It is vital in hematopoietic stem cell transplantation, where HLA marker compatibility is essential for successful engraftment and GVHD prevention. Additionally, HLA typing aids in diagnosing autoimmune diseases, as certain HLA alleles correlate with conditions like celiac disease and type 1 diabetes. As the use of HLA typing expands into various healthcare sectors, the demand for related products and services is anticipated to rise, further propelling market expansion.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global HLA Typing for Transplant Market”
Precision medicine, which customizes medical treatments to individual patients based on their genetic characteristics, is gaining traction in transplantation. HLA typing plays a crucial role in identifying optimal donor-recipient matches, reducing the risk of graft rejection, and enhancing transplant outcomes. With precision medicine becoming more mainstream, the demand for precise and comprehensive HLA typing for transplantation is projected to increase, stimulating market expansion.
The incidence of chronic diseases like end-stage renal disease, cardiovascular diseases, and liver diseases is on the rise worldwide. Many of these conditions necessitate organ transplantation as a treatment modality. As the prevalence of chronic diseases escalates, so does the need for HLA typing to facilitate successful organ transplants. The mounting burden of chronic illnesses is anticipated to boost the demand for HLA typing for transplantation, driving market growth.
The Global HLA Typing for Transplant Market is
segmented into Product & Service , Technology, Application, Transplant
Type, Regional Distribution, And Company.
Based on the Application, Diagnostic Applications
emerged as the dominant segment in the global market for Global HLA Typing for
Transplant Market in 2023. Diagnostic applications of
HLA typing are fundamental to the process of organ and tissue transplantation.
These applications are essential for ensuring compatibility between donors and
recipients, which is paramount to minimize the risk of graft rejection,
graft-versus-host disease (GVHD), and other complications. Diagnostic HLA
typing is a prerequisite for successful transplantation, making it a critical
demand driver. Diagnostic applications are primarily utilized in organ and
tissue transplantation. Compatibility assessments are conducted to determine
whether a potential donor's HLA markers match those of the recipient. This
process is vital to secure successful transplant procedures, particularly in
life-saving organ transplantations. HLA typing for diagnostic applications is
required for a wide range of transplant procedures, including kidney, liver,
heart, lung, pancreas, and corneal transplants, to name a few. The need for
accurate HLA typing in these diagnostic applications is consistent and
widespread, leading to high demand.
North America emerged as the dominant
player in the Global HLA Typing for
Transplant Market in 2023, holding the
largest market share. North America possesses an advanced and robust healthcare infrastructure, comprising cutting-edge clinical laboratories, healthcare facilities, and transplant centers renowned for their comprehensive HLA typing services. Utilizing the latest technologies and methodologies, North America stands as a global leader in the field of HLA typing. The region experiences substantial demand for organ and tissue transplants, fueled by its sizable population and the prevalence of conditions necessitating transplantation. Consequently, there exists a continuous requirement for precise HLA typing to facilitate successful transplant procedures. Countries in North America, notably the United States and Canada, adhere to well-defined regulatory frameworks and receive government support for organ transplantation endeavors. These regulations underscore the critical role of HLA typing in ensuring compatibility and patient safety. Adherence to these standards ensures widespread adoption of HLA typing practices throughout the region.
Major companies operating in Global HLA Typing
for Transplant Market are:
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Qiagen N.V.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Immucor, Inc.
- Caredx. Inc.
- Luminex Corporation (Diasorin)
- Tbg Diagnostics Limited
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“The Global HLA
Typing for Transplant Market is poised for significant growth in the coming
years. The aging global population is on the rise, leading to an increased
prevalence of urological and cardiovascular conditions that require
catheterization. Secondly, the growing awareness of infection control and
patient comfort is driving healthcare providers and patients to favor HLA
Typing for Transplant over reusable options. Thirdly, advancements in medical
technology are continuously enhancing the quality and ease of use of disposable
catheters, making them more attractive to both healthcare providers and
patients. Finally, the trend of home-based care is expected to boost the demand
for disposable catheters, as they offer a convenient and hygienic solution for
patients managing their conditions in the comfort of their homes”, said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies), By Application (Diagnostic Applications, Antibody Screening, Chimerism Monitoring, Research Applications, Others), By Transplant Type (Solid Organ Transplant, Soft Tissue Transplant) Region and Competition, 2019-2029F”, has evaluated the future growth
potential of Global HLA Typing for Transplant Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global HLA Typing for Transplant Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com